In conclusion, our study identified nine key regulators, of which COL11A1, MMP11 and COL10A1 were up regulated and PCOLCE2, LAMA2, TMTC1, ADAMTS5, TIMP4 and RSPO3 were down regulated in breast cancer samples as compared to control samples. Here, ADAMTS5 is linked to breast carcinoma.